Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence
This study has been completed.
Information provided by (Responsible Party):
Laura Armas, Creighton University
First received: May 22, 2012
Last updated: March 25, 2014
Last verified: March 2014
Type 1 Diabetes Mellitus is a disease that has an effect on bone mineral density. It is unclear how and when it effects the bone density. The investigators are studying the effects of diabetes on bone mass compared to children without diabetes.
||Observational Model: Case-Only
Time Perspective: Prospective
||Type 1 DM Bone Mineral Density in Childhood and Adolescence
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||May 2013 (Final data collection date for primary outcome measure)
Patients with Type 1 Diabetes Mellitus
|Ages Eligible for Study:
||5 Years to 18 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Children and adolescents with Type 1 DM
- We will recruit children from age 5 to age 18 with a diagnosis of Type 1 DM. Children will have various lengths of time since diagnosis.
- We will exclude children on anticonvulsants or steroids and children with other concomitant illnesses that interfere with bone mass accrual, except for hypothyroidism on treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01605149
|Omaha, Nebraska, United States, 68131 |
||Laura AG Armas, MD
No publications provided
||Laura Armas, Assistant Professor, Creighton University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||May 22, 2012
||March 25, 2014
||United States: Institutional Review Board
Keywords provided by Creighton University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on February 27, 2015
Diabetes Mellitus, Type 1
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases